Literature DB >> 26759459

Conquering Metastatic Breast Cancer.

Nancy E Davidson1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26759459      PMCID: PMC4960463          DOI: 10.1200/JOP.2015.009167

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  8 in total

1.  Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.

Authors:  H Gilbert Welch; David H Gorski; Peter C Albertsen
Journal:  N Engl J Med       Date:  2015-10-29       Impact factor: 91.245

Review 2.  Curing Metastatic Breast Cancer.

Authors:  George W Sledge
Journal:  J Oncol Pract       Date:  2016-01       Impact factor: 3.840

3.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

Review 4.  Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.

Authors:  Kala Visvanathan; Patricia Hurley; Elissa Bantug; Powel Brown; Nananda F Col; Jack Cuzick; Nancy E Davidson; Andrea Decensi; Carol Fabian; Leslie Ford; Judy Garber; Maria Katapodi; Barnett Kramer; Monica Morrow; Barbara Parker; Carolyn Runowicz; Victor G Vogel; James L Wade; Scott M Lippman
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

5.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

6.  Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2015-07-23       Impact factor: 79.321

7.  The Path to Cancer --Three Strikes and You're Out.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  N Engl J Med       Date:  2015-11-12       Impact factor: 91.245

Review 8.  The AURORA initiative for metastatic breast cancer.

Authors:  D Zardavas; M Maetens; A Irrthum; T Goulioti; K Engelen; D Fumagalli; R Salgado; P Aftimos; K S Saini; C Sotiriou; P Campbell; P Dinh; G von Minckwitz; R D Gelber; M Dowsett; A Di Leo; D Cameron; J Baselga; M Gnant; A Goldhirsch; L Norton; M Piccart
Journal:  Br J Cancer       Date:  2014-09-16       Impact factor: 7.640

  8 in total
  1 in total

1.  Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.

Authors:  Yao Wong; Akshara Singareeka Raghavendra; Christos Hatzis; Javier Perez Irizarry; Teresita Vega; Nina Horowitz; Carlos H Barcenas; Mariana Chavez-MacGregor; Vicente Valero; Debu Tripathy; Lajos Pusztai; Rashmi K Murthy
Journal:  Oncologist       Date:  2018-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.